Our Network of Consultants

I am an experienced immunology scientist and strategic research professional with over seven years of experience translating complex science into actionable solutions for gene and cell therapy innovation. My expertise spans target discovery, assay development, and preclinical validation in oncology and autoimmune disease. I currently lead cross-functional research guiding data-driven decisions that accelerate candidate selection and advance therapeutic programs toward clinical development.

I bring a unique blend of technical depth and strategic perspective, skilled in multi-colour flow cytometry, viral vector design, and in vivo preclinical models, while adept at troubleshooting, stakeholder communication, and aligning scientific outputs with project milestones. I excel at bridging science and strategy, supporting decision-making that drives efficiency, innovation, and measurable outcomes.

During my PhD at King’s College London, I developed a novel non-invasive quantification method for CAR T cell activity and presented my work internationally. My research has been published in Nature Medicine, Cancer Cell, and Science Advances. I am passionate about applying scientific insight and strategic problem-solving to help organisations optimise R&D strategies, de-risk innovation, and translate discovery into real therapeutic and business value.

Marketing strategist and AI commercialisation specialist. I help technically complex companies turn AI investment into commercial capability that boards, sceptics, and revenue lines can all defend.

I believe the customer belongs at the centre of every commercial decision. Holding them there is the hard part.

The buyer gets researched once, then slowly fades from view. Internal reviews, approval chains, and competing priorities pull the work away from the person it was meant to serve. I call this organisational gravity, and it erodes buyer-centric thinking inside even the most disciplined companies.

Synthetic customers are how to keep the buyer present. Built from real voice-of-customer evidence, they let teams interrogate buyer perspective at any stage of a commercial process, long after the original research has faded from memory. The buyer stays in the loop.

I am a marketing strategist first, working at the intersection of science, technology, and commercial growth, and adopt and build with AI faster than most of my field. That blend of deep domain fluency and early AI craft is what turns buyer insight into commercial outcomes that survive internal scrutiny.

I holds a PhD in Chemistry from the University of Bristol, an MBA from Cranfield School of Management, and BSI certification in AI Management Systems (ISO/IEC 42001:2023), one of a small number of practitioners globally to hold that credential. I write for Forbes and am authoring my own book on this topic matter.

Senior Molecular Biologist with 35+ Years of International Experience (Europe/USA)
Expertise: Gene Therapy (rAAV & Lentiviral Vectors), Synthetic Biology, Molecular Biology, Biochemistry, and Cell Biology across Mammalian, Bacterial, Yeast, and Plant Systems
 Specialised in:
- Advanced Vector Engineering: Design and validation of custom plasmids for specific in vivo and in vitro assay requirements; expression cassette engineering by selecting promoters, enhancers, regulatory elements, and seqeunce optimisation (species-tissue optimisation); tailoring of cloning and assembly methods and validation; safety and manufacturability.
- Construct Stability: Troubleshooting DNA instability challenges such as repeated sequences, ITR, GC-rich sequences, and gene toxicity.
- Regulatory Practices: Design of GMP-compliant workflows, documentation, and manufacturing alignment.

With over a decade of experience in Sales, Account Management, and Business Development across Europe, I bring a proven track record of growing revenue, structuring global sales operations, and managing complex biopharmaceutical relationships. My expertise spans both services and capital equipment (CAPEX) sales, with a consistent history of exceeding targets and closing multimillion-pound deals at executive level.

I currently operate as a Business Development and Sales Consultant for Cellevate AB and LiveDrop Bio, where I designed and implemented complete business development strategies, built CRM systems and performance dashboards, and positioned the companies among key academic and biopharma stakeholders. My recent achievements include generating leads and converting them into purchase orders through strong technical presentations and relationship-building with KOLs, CROs, and manufacturing partners.

Previously, as Global Key Account Manager at Miltenyi Biotec, I managed six global customers totaling 23 international sites, negotiated supply agreements, and developed multi-year growth strategies. I notably closed a £3.3 million CAPEX deal within two weeks and contributed €35 million toward the 2024 revenue plan. At Sartorius Stedim, I led high-value accounts across France, Benelux, and the UK, expanding revenue by more than 200% year-on-year while coordinating multi-site collaborations across R&D and manufacturing.

My career demonstrates a unique combination of scientific literacy and commercial strategy. I began in technical sales roles with Sartorius and BD, where I introduced innovative single-cell and flow cytometry technologies, managed market entry strategies, and won back blacklisted accounts through consultative negotiation. Over time, I transitioned into strategic sales leadership—defining go-to-market frameworks, establishing KPIs, and mentoring sales representatives across divisions and regions.

Fluent in both English and French, I excel in cross-cultural communication and high-level stakeholder engagement. My skill set spans consultative and strategic selling, global account mapping, contract negotiation, and profit planning. Equipped with deep knowledge of the biopharma value chain—from cell and gene therapy manufacturing to clinical and CDMO partnerships—I operate effectively within matrixed organizations and thrive in fast-evolving innovation environments.

Certified in advanced selling methodologies (Sandler, Miller Heiman, Mercuri) and completing PRINCE2 accreditation, I combine technical expertise, legal understanding, and business acumen to deliver sustainable commercial growth in the life sciences sector.

Strategic Product Management/Marketing Leader with 25+ years of experience in life sciences, specializing in product management, new product development, developing global marketing strategy within the IVD, oncology, and infectious disease markets. Extensive experience leading multifunctional teams, building stakeholder relationships, and launching products involving advanced technologies, including NGS.

With more than 10 years of R&D experience in biochemistry and infection biology, I am a Senior Scientist for Surface Chemistry in Biotechnology at e-Proteins, the world leader in avidin derivatives production. I have been applying my expertise and skills to develop innovative binding protein solutions for diagnostic, biotech, and pharma industries, addressing the main challenges of streptavidin-based applications.

As a team leader and co-founder of Sapoto, I have also been managing and coordinating a team of 30 employees, integrating external service providers, and overseeing the quality management activities for other test centers. I hold the credentials of QMB Manager and Internal Auditor, which enable me to ensure compliance with GMP, GLP, and GCP standards. My mission is to contribute to the advancement of biotechnology and improve the quality and reliability of binding protein products.